OpenAlex
PricingAboutJobs
Log inGet started
Work

Discontinued drugs in 2012: oncology drugs

HTML

Year: 2013
Type: article
Source: Expert Opinion on Investigational Drugs
DOI: 10.1517/13543784.2013.847088
Author: Robert Williams
Institution: Cancer Research UK
Language: English

Topic: Pharmaceutical Economics and Policy
Subfield: Economics and Econometrics
Field: Economics, Econometrics and Finance
Domain: Social Sciences
Keywords: drug discontinuation, oncology drugs, anticancer drug development, phase III trial failure, pharmacodynamic biomarkers, drug development efficiency, new drug approvals
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2035866144
FWCI: 6.901
Cites: 11
Cited by: 41
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security